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Abstract
Background: Ten million Americans enter jails annually. The objective was to evaluate new CDC guidelines for routine opt-
out HIV testing and examine the optimal time to implement routine opt-out HIV testing among newly incarcerated jail
detainees.
Methods: This prospective, controlled trial of routine opt-out HIV testing was conducted among 323 newly incarcerated
female inmates in Connecticut’s only women’s jail. 323 sequential entrants to the women’s jail over a five week period in
August and September 2007 were assigned to be offered routine opt-out HIV testing at one of three points after
incarceration: immediate (same day, n=108), early (next day, n=108), or delayed (7 days, n=107). The primary outcome
was the proportion of women in each group consenting to testing.
Results: Routine opt-out HIV testing was significantly highest (73%) among the early testing group compared to 55% for
immediate and 50% for 7 days post-entry groups. Other factors significantly (p=0.01) associated with being HIV tested were
younger age and low likelihood of early release from jail based on bond value or type of charge for which women were
arrested.
Conclusions: In this correctional facility, routine opt-out HIV testing in a jail setting was feasible, with highest rates of testing
if performed the day after incarceration. Lower testing rates were seen with immediate testing, where there is a high
prevalence of inability or unwillingness to test, and with delayed testing, where attrition from jail increases with each
passing day.
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Introduction
Over 2.3 million people, or one in every 100 American adults,
are incarcerated and their initial interface with the correctional
system is usually via jail.[1,2] The prevalence of HIV infection in
the United States is several-fold greater in correctional settings
than in the general population. [3] Jails and prisons thus serve as
important sites for HIV testing and treatment. [4,5,6,7] The
Centers for Disease Control and Prevention’s (CDC) recent
recommendation to implement routine opt-out HIV testing in all
healthcare settings, including jails, has not been achieved due to
logistical, financial and legal constraints.[8] Systematic solutions to
logistical constraints within correctional settings, however, pro-
vides an important opportunity to advance our public health goals
and expand access to HIV services for this vulnerable popula-
tion.[9,10,11]
Jails interact with a large number of individuals at risk for HIV
infection and pose unique logistical and health-related constraints
that impact HIV testing strategies. [12] Jails, compared to prisons,
are characterized by higher rates of turnover,[13] shorter stays, a
higher prevalence of acute intoxication and withdrawal, and a
higher number of inmates presenting with uncontrolled mental
illness, recent HIV risk behaviors [14,15] and suicidal behavior.
[16,17,18,19] Suicide incidence is three-times greater in jails than
in prisons, with nearly a quarter taking place within 48 hours of
admission.[20,21]
Given the high attrition rate in jails, a major logistical challenge
to implementing routine opt-out HIV testing is selecting the
optimal time to conduct testing.[22] Newly incarcerated inmates
might be too intoxicated or psychologically distressed to reliably
consent to or opt out of routine testing, and may be unprepared to
consider and respond to the consequences of a preliminary positive
HIV test result.[12,23] Likewise, the public health challenge with
postponing HIV testing is that many individuals experience
relatively short stays in jail and will be released before being
tested.[24,25]
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optimal time to conduct routine opt-out HIV testing of newly
incarcerated jail inmates in a manner that maximized the number
of individuals capable of consenting and willing to be tested.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Ethics Statement
This study was approved by the Institutional Review Board at
Yale University and by the Connecticut Department of Correction
Research Committee.
Design Overview
Over a 5-week period starting August 22, 2007, all 323
consecutive, newly incarcerated female inmates were offered
routine opt-out HIV testing after being sequentially assigned to
one of three study arms upon admission to the facility: 1)
‘immediate’ (during a mandatory initial medical screen the night
of admission); 2) ‘early’ (during a required physical exam the
following evening); or 3) ‘delayed’ (7 days after arrival to the
facility). Decisions about timing for routine opt-out HIV testing
were based upon previous surveys of correctional and medical
professionals as well as from experts in the field of HIV testing in
correctional settings. These three time points were chosen to
coincide with other routine healthcare activities at the jail in order
to simulate the future implementation of a routine opt-out HIV
testing protocol.
Setting and Participants
This prospective, controlled trial was conducted at York
Correctional Institution in Niantic, Connecticut, the state’s sole
correctional facility for women. Intake involves both sentenced
and pre-trial detainees. The average daily census is 1641 inmates.
Similar to other jails, a brief, standardized medical and psychiatric
assessment is routinely conducted on all inmates, including
medical, sexual, and drug-use histories immediately upon arrival.
Testing for pregnancy, opioids, tuberculosis and acute medical
conditions is routinely conducted. Inmates maintained on or
experiencing opioid withdrawal symptoms are provided a
methadone taper. The evening following admission, a routine
physical examination, including Papanicolaou smear and phlebot-
omy, occurs in all new inmates remaining within the facility. [26]
Voluntary HIV testing is available by medical referral or by self-
request and often involves a waiting list. Inmates with self-reported
HIV risks within the previous 90 days are deferred testing. Newly
confirmed HIV positive test results are reported to the Connecti-
cut Department of Public Health.
As part of this study, all newly incarcerated inmates were
sequentially approached for competency and HIV testing and
sequentially assigned to one of the three study groups. Eligibility to
be HIV tested required demonstration of competency by: 1)
clinician-confirmed ability to demonstrate knowledge of the risks,
benefits, and consequences of HIV testing in accordance with the
MacArthur Competence Assessment Tool for Clinical Research
[MacCAT-CR][27]; and 2) no self-reported suicidal ideation or
evidence of mental instability.
Intervention
For each testing group, the inmate was approached with the
following scripted statement: ‘‘As part of your regular medical
care, HIV testing can now be done using an oral swab that you
swipe across your gums. You can receive your results after 20
minutes. Would you like to be tested at this time?’’ If the inmate
responded affirmatively, she was instructed to self-administer the
oral HIV test by the clinical staff in the ‘immediate’ and ‘early’ test
groups as part of routine clinical activities in order to simulate how
routine opt-out HIV testing would be performed if not embedded
within a complicated research study. On day 7, research personnel
oversaw the verbal consent and self-administration procedures
using the same process. All subjects were instructed that HIV
results require minimal waiting. Anyone not wanting to know HIV
test results was not swabbed. If the inmate agreed to be swabbed
and tested, she subsequently met with a research assistant who
discussed two written informed consents – one for study
participation and one for HIV testing (legislatively mandated).
Inmates who initially agreed to be swabbed but refused to provide
both written consents did not have their HIV swabs tested and
these specimens were immediately discarded. These individuals,
along with anyone not wanting testing were informed voluntary
HIV testing was available through self-referral from an HIV
counselor. Those who self-identified as being HIV-infected were
not swabbed.
Outcomes and Follow-up
Oral swab testing was conducted onsite using the OraQuick
ADVANCEH rapid HIV-1 antibody test [sensitivity: 99.3% (98.4–
99.7), specificity: 99.8% (99.6–99.9)].[28,29] The primary out-
come was the proportion of individuals in each assigned group that
provided verbal consent to be swabbed for HIV testing.
Individuals were not swabbed for HIV testing if they were
physically not available (e.g., released from jail, at court, attorney
visits, too ill), were deemed medically incompetent to provide
consent, or opted out of HIV testing. The primary outcome, using
a public health perspective, was analyzed using an intention-to-
treat (ITT) approach and included all 323 inmates admitted to the
jail during the study period, as assigned. In our intention-to-treat
analysis, we assessed whether an inmate was swabbed, regardless
of whether they subsequently agreed to take part in the research
protocol. Any subject for whom swab results were missing were
deemed ‘‘failure to swab’’ in the analysis; however, there were no
missing data in the final database. A secondary outcome, to assess
individual acceptability of HIV testing, was the proportion of
inmates who agreed to HIV testing among those still under
correctional supervision at the time that testing was offered.
Pre-test counseling was not provided. Subjects who received a
preliminary positive test result were immediately referred for
phlebotomy for confirmatory testing with Western blot. Certified
HIV counselors provided preliminary-positive post-test counseling
and confirmatory results; study staff delivered negative results.
As an additional secondary analysis, inmates deemed competent
to receive testing who provided written consent were asked about
previous HIV testing experiences, attitudes toward HIV testing in
jail settings and were also administered a series of standardized
instruments: Clinical Opiate Withdrawal Scale [COWS], [30]
Clinical Institute Withdrawal Assessment of Alcohol Scale
[CIWA-Ar], [31] and the Kessler 6-Item Psychological Distress
Scale (K6).[32]
To determine if the three testing groups differed with regard to
social and demographic characteristics, the Connecticut Depart-
ment of Correction (CTDOC) database was queried to abstract
demographic characteristics [age and race (defined by CTDOC)],
type of charge and bond value. No unique identifiers were
provided. Low likelihood of early release was defined as a bond
value $$5,000, sentencing .30 days, immigration or federal
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considered to be any charges directly related to prostitution or
drugs.
Statistical Analysis
The primary outcome was the proportion of women in each
testing group who were orally swabbed and provided verbal
consent to receive rapid HIV testing. Using two-sided Chi-Square
tests for assessing three pair-wise differences between the different
study arms and applying Bonferroni’s correction (i.e.,
alpha=0.0166 for each comparison), we sought to collect 97
patients in each arm to achieve 80% power to detect a 22%
difference between arms given a baseline uptake of 60%.
Comparisons of demographic, correctional and refusal character-
istics were conducted using two-sided Chi-Square tests
(alpha=0.05).
After calculating the bivariate associations with the primary
outcome, a multiple logistic regression model was developed to
predict the likelihood of being swabbed using the available subject
characteristic variables. The Akaike information criterion (AIC)
was used to assess model fit; lower AIC values indicate a better
balance of parsimony and explanation of variance. In conjunction
with AIC, a p-value of 0.30 was used to enter and leave the model.
The optimal model was chosen as the convergence of the forward
and backward models, with consideration of parsimony and
plausibility. The two-sided Wald’s test (alpha=0.05) was used to
assess significance of each of the variables. All statistical analyses
were conducted using SAS, version 9.1.3 (SAS Institute).
Results
The baseline characteristics of the study population are shown
in Table 1. During the study period, 323 newly incarcerated
women were sequentially assigned to the following testing groups:
‘immediate’ (N=108, the night of admission), ‘early’ (N=108, the
following evening), and ‘delayed’ (N=107, 7 days later). The three
study groups did not differ significantly with respect to any of the
social and demographic characteristics assessed.
The disposition of individuals approached for routine opt-out
HIV testing in this trial is illustrated in Figure 1. Overall, 192
(59%) of 323 inmates assigned to testing groups provided verbal
consent to be swabbed for HIV testing. For the primary outcome,
79 (73%) of those offered ‘early’ testing, received an HIV test,
compared to 59 (55%) assigned to the ‘immediate’ and 54 (50%)
assigned to the ‘delayed’ testing groups (Figure 2). The early
testing group was significantly more likely to be tested than both
the immediate group (OR=2.3; 95% CI=1.3–4.0; p=0.007) and
the delayed group (OR=2.7; 95% CI=1.5–4.7; p=0.0007). The
proportion swabbed in the immediate and delayed testing groups,
however, did not differ (OR=1.2; 95% CI=0.7–2.0; p=0.54).
To assess the individual acceptability of HIV testing, 268 subjects
were physically present within the jail at the three time points
when routine opt-out testing was made available (see Figure 2).
Acceptability was highest for the early testing group (N=79/91,
87%), compared to 76% (N=54/71) in the delayed and 56%
(N=59/106) in the immediate testing group (p,0.05 for all
comparisons).
Stratified by testing group, the reasons that inmates were not
swabbed are depicted in Table 2. In the ‘immediate’ group
(N=108), 12 (11%) were medically incompetent to consent,
compared with only 4 (4%) in each of the ‘early’ (N=108) and
‘delayed’ (N=107) testing groups. This difference was significant
(OR=3.2; 95% CI=1.3–8.2; p=0.009; not depicted in Table 2).
In the ‘delayed’ testing group, 36 (34%) did not appear for testing
compared with 4 (4%) in the ‘immediate’ and 17 (16%) in the
‘early’ testing groups (OR comparing delayed to other: 4.7; 95%
CI: 2.6–8.6; p=0.000001; not depicted in Table 2). The most
common reasons for failing to be available for testing included
Table 1. Baseline Characteristics of the Study Population (n=323).
Characteristics Subcategory Value (%)
Age (mean years; SD) 33.6 (9.8)
Length of Current Incarceration (median days; IQR) 28 (7–94)
Race Hispanic 53 (16)
Black 104 (32)
White/Other 166 (51)
Education High School Graduate 201 (62%)
Not a High School Graduate 122 (38%)
Likelihood of Early Release* High 115 (36)
Low 208 (64)
Type of Charge Drug- or Prostitution-Related 81 (25)
Not Drug- or Prostitution-Related 242 (75)
Previous Incarcerations Never Incarcerated 117 (36)
Incarcerated Previously 206 (64)
Mean Number of Previous Incarcerations (N; SD) 1.9 (2.4)
Medical Insurance Yes 120 (37)
No 203 (63)
Urine Toxicology Negative for Opiates 242 (75)
Positive for Opiates 81 (25)
*High: any charges directly related to prostitution or drugs.
Low: bond value $ $5000, bond sentencing .30 days, immigration or federal charges, or no bond.
doi:10.1371/journal.pone.0007648.t001
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Figure 2. Rapid HIV Testing Swab Results by Assigned Testing Group.
doi:10.1371/journal.pone.0007648.g002
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court), appearing in court that day, or rarely, logistical barriers
within the jail setting that prevented movement within the facility.
Among the 54 competent subjects who declined testing, 27 (54%)
stated they did not perceive themselves at risk, 10 (19%) declared
they were already HIV-infected (all were confirmed by medical
record review), and 8 (15%) stated they were too tired, fearful of
testing, or experiencing withdrawal.
Figure 3 demonstrates the first attrition-decay curve from a jail
expressed over time. The median duration of incarceration was 28
days; among the 323 subjects approached, 90 (28%) were no
longer incarcerated after 7 days, 118 (37%) after 14 days, and 247
(76%) at 90 days after admission. The highest attrition rate was
within the first 24 hours with 11% (n=34) leaving the facility
during this time. These individuals, compared to those who were
released at later times, trended toward having less opiate-positive
urine test results (11% vs. 26%, p=0.06) and were less likely to be
jailed for sex- or drug-related charges (11% vs. 26%, p=0.06).
They were also significantly less likely to have been previously
incarcerated (43% vs. 66%, p=0.009). Bivariate and multivariate
analyses were conducted to determine predictors associated with
being swabbed for HIV testing (Table 3). In the bivariate analysis,
assignment to the ‘early’ testing group, younger age, low-likelihood
of release, high HIV-risk charges, and being Hispanic were
associated with being swabbed for HIV testing. In the multivariate
analysis, assignment to the ‘early’ testing group (p,0.001),
younger age (p=0.01), and low likelihood of release (p=0.01)
remained significantly associated with being swabbed for HIV
testing.
Of the 192 individuals who were swabbed, 151 (79%) provided
written consent to complete the entire study. Two additional
participants failed to pass the MacArthur Competence Assessment
Tool, leaving 149 (79%) individuals eligible to be HIV tested. Of
these, 147 (99%) were HIV-negative and two had a preliminary-
positive test result; both results were false-positive after obtaining
confirmatory Western Blot testing. Thus, none of the 149 people
tested were diagnosed as being HIV-infected. Two negative test
results (one from the ‘immediate’ and one from the ‘early’ testing
groups) were not delivered due to the inmate having left the
facility.
Among the 149 subjects HIV-tested subjects that underwent
standardized screening, 11 (7%) exhibited moderate or severe
opioid withdrawal symptoms: three (7%) from ‘immediate’, eight
(15%) from ‘early’ group, and none from the ‘delayed’ testing
group. Ten (7%) individuals were deemed to have increased risk
for alcohol withdrawal symptoms: three (7%) from ‘immediate’,
seven (13%) from ‘early’, and none from the ‘delayed’ testing
group. In addition, 50 (34%) of the 149 tested subjects had
evidence of serious mental illness using the K6 psychological
distress scale score: 11 (24%) from ‘immediate’, 22 (42%) from
‘early’, and 17 (33%) from the ‘delayed’ testing group. Nearly all
(89%) of these 149 subjects self-reported having been HIV tested
previously, but only 32% reported testing within the previous year.
The most recent HIV testing had occurred previously at a
Table 2. Reasons Inmates were not Swabbed for HIV Testing.
Reason Immediate Group Early Group Delayed Group
(49 not swabbed of 108) (29 not swabbed of 108) (53 not swabbed of 107)
Bonded/Released/At Court, n (%) 4 (8) 17 (59) 36 (68)
Refused/Declined Swab or Study Participation, n (%) 33 (67) 8 (27) 13 (24)
Medically Incompetent/Failed MacArthur, n (%) 12 (25) 4 (14) 4 (8)
doi:10.1371/journal.pone.0007648.t002
Figure 3. Time to Release Following Incarceration.
doi:10.1371/journal.pone.0007648.g003
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correctional facility (n=29, 19%).
Discussion
To our knowledge, this is the first prospective, controlled trial of
routine opt-out HIV testing among female jail inmates, a
population that typically experiences high rates of psychological
distress, rapid turnover, and both acute intoxication and
withdrawal upon admission. Previously, voluntary testing had
been shown to have limited uptake rates; one multicenter study
tested only 6% of ,550,000 jail detainees using voluntary testing
methods. [33] Two observational studies had suggested that
routine opt-out HIV testing was feasible.[23] Our results confirm
the feasibility of opt-out, routine rapid HIV testing in a jail setting
and suggest that waiting until the evening after entry increases the
number of individuals who receive HIV testing. This is likely due
to optimizing the balance between allowing time for psychological
and medical stabilization of the individual and expeditiously
providing testing prior to individuals leaving the facility. The
magnitude of these effects are of significant public health
importance, in that 73% of those approached the evening after
admission were swabbed for HIV testing, compared to 55% and
50% of those approached immediately or seven days post-entry,
respectively. This benefit was seen despite the fact that 11% of
inmates at this facility were released within the first 24 hours.
Similarly, individual acceptability of HIV testing was also
highest among those in the early testing group. Of the 268 women
physically present in the facility at the time they were offered, 87%
of those approached the evening after admission verbally
consented to testing, compared to 56% and 75% of those in the
immediate and delayed testing groups, respectively. Testing
inmates on the day of incarceration may be less optimal because
these individuals are distraught from being arrested and tired from
remaining in court or in a holding cell all day. The substantial
increase in willingness to test 24 hours after admission may reflect
acceptance of being incarcerated, in addition to having had a night
of sleep. Though unclear from these data, acceptability decreased
after remaining in the jail after 7 days, perhaps explained by the
impact of peer pressure and/or recognition of potential stigma
from HIV testing. Despite acceptability being slightly lower among
those individuals approached for testing one week post-entry, a
higher proportion consented than found in voluntary HIV testing
programs in other correctional settings.[33,34]
Because this study was restricted to a single, female correctional
facility, the findings may not be generalizable to all jail settings.
Not all jails provide routine clinical assessments the day following
admission, and others may not provide any routine healthcare
services at all.[35] Furthermore, large, metropolitan correctional
facilities experiencing many-fold higher daily admissions may face
additional logistical challenges in implementing testing as part of
intake procedures. Finally, gender differences may also result in
markedly different uptake rates of HIV testing among male
inmates compared to females.
In this study, the most common reasons for not being swabbed
for HIV testing included early release from the facility (presumably
due to posting bond), failing to demonstrate medical competency
to consent to testing, and choosing not to be HIV tested. On
multivariate analysis, additional factors significantly associated
with receiving HIV testing were younger age (conferring a 7%
decrease in the likelihood of testing for every ten years of
increasing age) and having bond set above $5,000 (conferring
nearly a 2-fold reduced likelihood of being released). Ability or
willingness to test was particularly important for testing in the
Table 3. Bivariable and Multivariable Predictors of Receipt of Swab.
Uptake Rates, n (%) Bivariable OR (95% CI) Bivariable p-value Multivariable OR (95% CI) Multivariable p-value
Assigned day 0* 59 (55) 1.2 (0.7 to 2) 0.54 1.2 (0.7 to 2.1) 0.51
Assigned day 1* 79 (73) 2.7 (1.5 to 4.7) 0.0007 2.7 (1.5 to 5) 0.0009
Assigned day 7* 54 (50) --Referrent-- -- --Referrent-- --
Age (yrs) at Entry** -- 0.7 (0.6 to 0.9) 0.01 0.7 (0.6 to 0.9) 0.01
Low Likelihood of Release 133 (64) 1.7 (1.1 to 2.7) 0.03 1.9 (1.1 to 3.1) 0.01
High Likelihood of Release 59 (51) --Referrent-- -- --Referrent-- --
High HIV-Risk Offense 56 (69) 1.7 (1 to 3) 0.04 1.7 (1 to 3) 0.07
Low HIV-Risk Offense 136 (56) --Referrent-- -- --Referrent-- --
Black 55 (53) 0.7 (0.4 to 1.1) 0.10 0.7 (0.4 to 1.2) 0.17
Hispanic 40 (75) 2.4 (1.2 to 4.7) 0.01 2 (1 to 4.1) 0.07
White/Other 97 (58) --Referrent-- -- --Referrent-- --
Previous Incarceration 125 (61) 1.2 (0.7 to 1.8) 0.55 -Out of Model- --
No Previous Incarceration 67 (57) --Referrent-- -- -Out of Model- --
Urine Opiate(+) 51 (63) 1.2 (0.7 to 2) 0.46 -Out of Model- --
Urine Opiate(-) 141(58) --Referrent-- -- -Out of Model- --
High School Graduate 118 (59) 0.92 (0.6 to 1.5) 0.73 -Out of Model- --
Not High School Graduate 74 (61) --Referrent-- -- -Out of Model- --
Has Medical Insurance 66 (55) 0.7 (0.5 to 1.2) 0.21 -Out of Model- --
No Medical Insurance 126 (62) --Referrent-- -- -Out of Model- --
*OR Comparing day 1 or day 7, respectively to day 0.
**The calculated OR represents the added likelihood conferred by every 10 years of age.
doi:10.1371/journal.pone.0007648.t003
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to ‘immediate’ testing refused testing (Figure 2), only 7% of those
approached one day later chose to opt-out. Those assigned to the
‘immediate’ testing group were also 3-times more likely than either
of the other groups to be medically or psychologically unable to
consent to testing. One potential explanation for the higher rate of
testing in the ‘early’ testing group, particularly compared to the
immediate group, is that women may have gotten some rest, been
initiated on medication-assisted protocols to treat opioid or alcohol
withdrawal, or had become resigned to being in jail.
It was clear that the high-risk women in this study had not been
adequately reached with HIV testing services. While 89% of those
who consented to study participation reported being previously
tested for HIV, only 30% had received an HIV test within the last
year, per CDC recommendations for high-risk individuals.
Our protocol achieved a reasonable balance of personal
autonomy and effectiveness so critical to achieving good outcomes
in correctional settings. [12,36] Using a routine opt-out HIV
testing program, those individuals who perceive themselves at
high-risk and are therefore fearful to test can still choose to not be
tested. Likewise, those who don’t perceive themselves to be at risk
may fail to take advantage of the opportunity to receive testing.
Over one-third of the 27 inmates who opted-out of HIV testing
would otherwise be deemed at significant risk for HIV, supported
by 4 (15%) testing positive for opiates and another 5 (19%)
arrested for prostitution or drug-related charges. These data
suggest that if an HIV testing strategy is to be implemented, it is
important that reasons for refusal are properly addressed to
optimize uptake of HIV testing among those who might be at
highest risk or may not recognize their risk at all.
A major strength of the present study design was that it enabled
us to accurately assess realistic acceptance for HIV testing in an
ethical manner. Socially marginalized individuals, such as
prisoners, may be leery about participating in research in coercive
places like jails. [2,37] We overcame this obstacle by asking jail-
based clinicians to ask individuals to provide verbal consent to be
HIV tested before referring them to research personnel to obtain
written consent for study participation. Thus, this trial simulated
what routine opt-out HIV testing within a clinical encounter in jail
might look like and avoids biasing participant response during the
encounter. Indeed, approximately 22% of those subjects who
agreed to be swabbed for rapid HIV testing as part of routine
intake procedures later refused to provide consent for study
participation. In most cases, this was because of subjects’ suspicion
of being involved in research or because of the time involved in
completing several interview instruments at a time when they were
tired or did not feel well. The primary outcome of being swabbed
for an HIV test, therefore, served as a better marker in this trial for
acceptance of HIV testing than completion of the informed
consent aspect of the study and thereby receiving an HIV test
result.
Although this trial successfully demonstrated the feasibility of
routine opt-out HIV testing in a jail, challenges remain to be
addressed before routine opt-out HIV testing is implemented more
widely in other jail settings. Daunting challenges remain to
implement routine opt-out HIV testing upon intake at some of the
largest and busiest jails. Several hundred people may be processed
daily, with intake procedures taking place 24 hours a day.
One of the unresolved issues for routine opt-out HIV testing in
jails is ensuring delivery of confirmatory HIV test results for those
who test preliminarily-positive. In this trial, only two (0.6%) of the
323 women approached for testing received a preliminary-positive
test result that required a confirmatory blood draw, the results of
which often require up to a week to receive. Although both
individuals in this trial were still incarcerated in the facility and
therefore able to receive their confirmatory results a week later,
there will be cases of release prior to receipt of results. Indeed, over
one-quarter of the inmates in this study were released within seven
days of entry. While we await more rapid, confirmatory testing
technology, Western Blot testing remains the accepted standard.
Therefore, establishing linkages to public health systems in the
community is required to ensure case-finding after release and
ensure delivery of confirmatory results.
We conclude that routine opt-out HIV testing in jails is feasible,
with the highest testing yield occurring one day after incarceration.
This approach balances the medical and psychiatric instability
seen among those immediately upon incarceration with the high
attrition rate demonstrated by those tested 7 days later.
Notwithstanding the merits of answering the logistical question
of when to HIV test, many other questions remain, including how
to avoid repeat testing, costs associated with increased HIV testing
and barriers associated with written informed consent.
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